Skip to Content

Publications

GAPConnect

October 2, 2012

Forming a global cancer network for research, clinical care, education and prevention.

Contact GAPConnect.


Highlights

Visiting Professorship in Gynecologic Oncology Goes to Nicaragua

 

You may recall past issues of GAP Connect discussing the Visiting Professorship in Gynecology Oncology, which is a resident training initiative in Central America originally initiated by Ted Trimble, M.D., current director of the National Cancer Institute's Center for Global Health and now sponsored by the International Gynecologic Cancer Society. At MD Anderson, the program started with Kathleen Schmeler, M.D., associate professor and Pedro Ramirez, M.D., professor in the Department of Gynecologic Oncology & Reproductive Medicine. The two began training residents in Guatemala in 2010 with the aim of increasing the number of trainees who pass the American Congress of Obstetricians and Gynecologists (ACOG) certification exam.

From September 24-27, 2012 Schmeler, along with Marcela del Carmen, M.D., who is Nicaraguan and works at Massachusetts General Hospital, visited Hospital Bertha Calderon in Managua and Hospital Escuela Oscar Danilo Arguelo (HEODRA) in Leon, Nicaragua. The two physicians spent three days with residents and then participated in the Nicaraguan Oncology Society annual meeting and are planning to return in July 2013, which will coincide with the annual Nicaraguan Obstetrics and Gynecologic Society meeting.

You can find more information about past visits and all the spanish language slides used in the lectures with resident's on GAP's website. You can also read about the last Visiting Professorship visit in January to El Salvador on GAP Connect.

Calendar of Events

Symposia on Cancer Research 2012
Houston, Texas
Sept. 21-22, 2012

DKFZ Stem Cell Symposium
Heidelberg, Germany
Oct. 14-16, 2012

Yonsei Joint Symposium
Seoul, Korea
Oct. 18-19, 2012

Announcements

MD Anderson Joint Conference and MOU Signing in El Salvador

From October 18-20, 2012, MD Anderson will participate in a joint symposium and signing of a Memorandum of Understanding with partners in El Salvador. The MOU will be signed by MD Anderson, Basic Health International (BHI) and the Ministry of Health in El Salvador as they strengthen their commitment to work cooperatively to impact cancer and especially highly preventable diseases like cervical cancer.

The effort to create this alliance has been spearheaded by Kathleen Schmeler, M.D., assistant professor from the Department of Gynecologic Oncology & Reproductive Medicine and she along with her colleagues Michael Frumovitz, M.D., associate professor in the same department and Patricia Eifel, M.D., professor in the Department of Radiation Oncology, will represent MD Anderson at the symposium.

Basic Health International, recently launched a new program in El Salvador using careHPV, a rapid test for HPV, the virus that causes cervical cancer. This ability to quickly and inexpensively screen women and determine if they need additional care keeps costs low in developing countries where the expense and complexity of a pap test makes it largely prohibitive. BHI's goal is to eradicate cervical cancer in Latin American and the Caribbean and has developed close ties with the Ministry of Health in El Salvador to work towards this aim. MD Anderson hopes to contribute to these efforts through the expertise of our physicians who are willing to contribute their time and effort.


Network News

MD Anderson Moon Shots News Release Translated into Spanish and Chinese

 

Español

El MD Anderson Cancer Center de la Universidad de Texas lanza Moon Shots, un programa sin precedentes
La iniciativa establece una nueva norma para erradicar el cáncer; su objetivo es aumentar considerablemente la supervivencia de los pacientes durante la próxima década.

HOUSTON, 21 de septiembre de 2012 – El MD Anderson Cancer Center de la Universidad de Texas anunció hoy el lanzamiento de Moon Shots, un programa sin precedentes para reducir considerablemente el plazo entre los descubrimientos científicos y su transformación en avances clínicos que permitan reducir las muertes por cáncer.

Chinese

德州大学MD 安德森癌症中心启动前所未有的“登月”项目
该项目设立了根除癌症的新标准; 目标是在未来十年内显著提高患者生存率

休斯敦,2012年9月21日—德州大学MD安德森癌症中心今天宣布,该中心启动了“登月”项目。该项目是安德森癌症中心前所未有的努力,旨在加速将科研发现转化为降低癌症死亡率的临床实践。
该项目最初以八种癌症为目标,将集中安德森癌症中心大量多学科研究人员和临床医生的力量,以协力攻治两种白血病:急性髓细胞白血病/骨髓增生异常综合症和慢性淋巴细胞白血病、黑色素瘤、肺癌、前列腺癌,以及在分子水平相连的三阴性乳腺癌和卵巢癌。

每个“登月”项目都将收到经费和所需的其他资源,以支持研发注重于患者疗效的创新性研究创见,包括基本研究、生物标记物驱动的临床实验、行为干预及公共政策措施等。

在第一个十年内,该项目的费用预计可能达到预期的三十亿美元。经费将几乎等量来源于慈善捐助、竞争性研究拨款以及新研发的商业效益。这些经费对安德森癌症中心的年度预算约七亿的所有癌症研究不会造成影响。事实上,该项目的工作,尤其是改善后的资源和基础设施,会有助于安德森癌症中心的所有其他癌症研究,因为最终目的是将在此过程中所获知识应用于所有癌症。